Wang Wang
Impact in
- Dermatology top 10%
- Dermatology and Skin Diseases
-
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- Immunotherapy and Immune Responses
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 4
-
- IL-33, ST2, and ILC Pathways 2
- Co-authors
- Yang Su (1 shared paper)Yuping Lai (1 shared paper)Xiaohu Wang (1 shared paper)Yuling Shi (1 shared paper)Xiaohong Zhao (1 shared paper)Jinling Huang (1 shared paper)Chen Dong (1 shared paper)Huiping Lu (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Nature Immunology (1 paper)Frontiers in Medicine (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Wang Wang
9 papers receiving 297 citations
Peers
Comparison fields: 5 of 62
- Dermatology 60
- Immunology 137
- Rehabilitation 23
- Infectious Diseases 65
- Pathology and Forensic Medicine 25
Countries citing papers authored by Wang Wang
This map shows the geographic impact of Wang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Wang more than expected).
Fields of papers citing papers by Wang Wang
This network shows the impact of papers produced by Wang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Wang. The network helps show where Wang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 121 | |
| 2 | 2022 | 62 | |
| 3 | 2022 | 37 | |
| 4 | 2024 | 33 | |
| 5 | 2021 | 20 | |
| 6 | 2021 | 11 | |
| 7 | 2022 | 9 | |
| 8 | 2025 | 4 | |
| 9 | 2025 | 2 |
About Wang Wang
Wang Wang is a scholar working on Infectious Diseases, Immunology, Dermatology, Rehabilitation and Molecular Biology, having authored 9 papers that have together received 299 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), vaccines and immunoinformatics approaches (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Dermatology and Skin Diseases (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Cancer-related molecular mechanisms research (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Dermatology (60 citations), Immunology (137 citations), Rehabilitation (23 citations), Infectious Diseases (65 citations) and Pathology and Forensic Medicine (25 citations). Wang Wang has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Yang Su, Yuping Lai, Xiaohu Wang, Yuling Shi, Xiaohong Zhao, Jinling Huang, Chen Dong, Huiping Lu, Xuexian O. Yang and Aishun Jin. Their work appears in journals such as Frontiers in Immunology, Nature Immunology, Frontiers in Medicine, Journal for ImmunoTherapy of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.